Moreover, in patients with aortic aneurysms, another cardiovascular disease where fibrosis is crucial, treatment with ACE inhibitors increased the levels of circulating type III procollagen peptide (PIIINP), suggesting active synthesis of COL385. This evidence concerns the gene ACE and cardiovascular disorder.